CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2018—ARUP Laboratories has added seven new genes to its Solid Tumor Mutation Panel by Next Generation Sequencing. The genes added are CTNNB1 (beta catenin), DDR2, MAP2K1, MTOR, NTRK1, ROS1, and TERT. This test identifies targeted variants that are useful for prognosis and/or treatment of individuals with solid tumor cancers, including melanoma, gastrointestinal stromal tumor, colorectal, bladder, and hepatocellular carcinomas, at initial diagnosis or in the presence of refracto-ry disease.
Pages: 1 2